Differential Risk Reduction of Gonorrhea and Chlamydia Among DoxyPEP Users Reporting High Adherence
CROI 2026 Feb 22-25 Denver
Michael P. Barry, PhD MPH1; Jason Bena, PharmD1; Jorge Roman, MSN1; Diana M. Tordoff PhD MPH2; Hyman Scott, MD MPH1,3
for (1) San Francisco AIDS Foundation | San Francisco, CA, USA; (2) Stanford University | Stanford, CA, USA; (3) San Francisco Department of Public Health | San Francisco, CA, USA
